News
Hikma buys rights to FDA-approved cancer treatment trametinib, a generic version of Novartis' (NVS) Mekinist, with 180 days ...
The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback